. Author manuscript; available in PMC: 2013 Jul 10.

Published in final edited form as: Psychol Med. 2010 Sep 22;41(6):1253–1261. doi: 10.1017/S0033291710001765

Table 2.

Associations Between Changes in Neurocognition and Social Cognition and Improved Functional Outcome (N = 58).

Variable	ΔFunctional Outcome
	Direct Effect^a					Mediator Effect^b

	B	SE	t	df	p	z′
ΔNeurocognition Composite	.15	.07	2.07	89	.041	1.50^*
ΔSocial Cognition (MSCEIT)
ΔPerceiving emotions	−.07	.07	−1.07	87	.288	−.98
ΔFacilitating emotions	−.05	.06	−.79	87	.434	−.63
ΔUnderstanding emotions	−.00	.07	−.01	87	.989	−.01
ΔManaging emotions	.14	.07	2.10	87	.038	1.56^*

Note. Results are based on mixed-effects regression models with a single social cognition variable as the primary covariate, adjusting for age, gender, IQ, illness duration, medication dose, and treatment assignment.

MSCEIT = Mayer-Salovey-Caruso Emotional Intelligence Test

Direct effects represent direct relations between changes in cognition and changes in functional outcome

Mediator effects represent the intervening effect of changes in cognition on CET effects on functional outcome

p < .05